261 related articles for article (PubMed ID: 32596739)
21. Clinical and microbiological characteristics of Staphylococcus lugdunensis.
Cronin KM; Moso MA; Chan E; Bond KA
Curr Opin Infect Dis; 2022 Dec; 35(6):524-529. PubMed ID: 36305373
[TBL] [Abstract][Full Text] [Related]
22. May Staphylococcus lugdunensis Be an Etiological Factor of Chronic Maxillary Sinuses Infection?
Kosecka-Strojek M; Wolska-Gębarzewska M; Podbielska-Kubera A; Samet A; Krawczyk B; Międzobrodzki J; Michalik M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742895
[TBL] [Abstract][Full Text] [Related]
23. Coagulase negative staphylococci - a fast emerging threat.
Latif M; Usman J; Gilani M; Munir T; Mushtaq M; Anjum R
J Pak Med Assoc; 2015 Mar; 65(3):283-6. PubMed ID: 25933562
[TBL] [Abstract][Full Text] [Related]
24. Detection of
Tekeli A; Öcal DN; Dolapçı İ
Balkan Med J; 2020 Jun; 37(4):215-221. PubMed ID: 32270947
[TBL] [Abstract][Full Text] [Related]
25. Cross-sectional study of Staphyloccus lugdunensis prevalence in cats.
Bierowiec K
Sci Rep; 2020 Sep; 10(1):15417. PubMed ID: 32963280
[TBL] [Abstract][Full Text] [Related]
26. Clinical and microbiological characteristics of community-acquired Staphylococcus lugdunensis infections in Southern Taiwan.
Wu AB; Wang MC; Tseng CC; Lin WH; Teng CH; Huang AH; Hung KH; Chiang-Ni C; Wu JJ
J Clin Microbiol; 2011 Aug; 49(8):3015-8. PubMed ID: 21697317
[TBL] [Abstract][Full Text] [Related]
27. Phylogenetic Distribution of CRISPR-Cas Systems in
Kao CY; Lu JJ; Lin LC; Lin HC; Chang SC
Microbiol Spectr; 2021 Dec; 9(3):e0124721. PubMed ID: 34851176
[TBL] [Abstract][Full Text] [Related]
28. Integron-Related Resistance in New Emerged Staphylococcus lugdunensis Infection in Burn Patients.
Pirbonyeh N; Emami A; Bazargani A; Javanmardi F; Hosseini SM; Derakhshan B
J Burn Care Res; 2020 May; 41(3):598-603. PubMed ID: 31867617
[TBL] [Abstract][Full Text] [Related]
29. Unbiased species-level identification of clinical isolates of coagulase-negative Staphylococci: does it change the perspective on Staphylococcus lugdunensis?
Elamin WF; Ball D; Millar M
J Clin Microbiol; 2015 Jan; 53(1):292-4. PubMed ID: 25339392
[TBL] [Abstract][Full Text] [Related]
30. Is Staphylococcus lugdunensis Significant in Clinical Samples?
Argemi X; Hansmann Y; Riegel P; Prévost G
J Clin Microbiol; 2017 Nov; 55(11):3167-3174. PubMed ID: 28835477
[TBL] [Abstract][Full Text] [Related]
31. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.
Frank KL; Del Pozo JL; Patel R
Clin Microbiol Rev; 2008 Jan; 21(1):111-33. PubMed ID: 18202439
[TBL] [Abstract][Full Text] [Related]
32. Two successfully treated cases of Staphylococcus lugdunensis endocarditis.
Chatzigeorgiou KS; Ikonomopoulou C; Kalogeropoulou S; Siafakas N; Giannopoulos G; Antoniadou A; Tassios PT; Tarpatzi E; Giannitsioti E; Vlachakos D; Ikonomopoulos T; Petinaki E; Zerva L
Diagn Microbiol Infect Dis; 2010 Dec; 68(4):445-8. PubMed ID: 21094427
[TBL] [Abstract][Full Text] [Related]
33. A case of vascular graft infection caused by Staphylococcus lugdunensis after femoropopliteal bypass operation.
Hagiya H; Matsumoto M; Yamasawa T; Haruki Y; Otsuka F
Acta Med Okayama; 2014; 68(3):171-5. PubMed ID: 24942796
[TBL] [Abstract][Full Text] [Related]
34. Staphylococcus lugdunensis: a neglected pathogen of infections involving fracture-fixation devices.
Seng P; Traore M; Lavigne JP; Maulin L; Lagier JC; Thiery JF; Levy PY; Roger PM; Bonnet E; Sotto A; Stein A
Int Orthop; 2017 Jun; 41(6):1085-1091. PubMed ID: 28405808
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): emergence of teicoplanin-non-susceptible CoNS strains with inducible resistance to vancomycin.
Ma XX; Wang EH; Liu Y; Luo EJ
J Med Microbiol; 2011 Nov; 60(Pt 11):1661-1668. PubMed ID: 21799199
[TBL] [Abstract][Full Text] [Related]
36. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
37. Genotypes and phenotypes of Staphylococcus lugdunensis isolates recovered from bacteremia.
Tseng SP; Lin YT; Tsai JC; Hung WC; Chen HJ; Chen PF; Hsueh PR; Teng LJ
J Microbiol Immunol Infect; 2015 Aug; 48(4):397-405. PubMed ID: 24388577
[TBL] [Abstract][Full Text] [Related]
38. Clinical and microbiological properties of Staphylococcus lugdunensis skin infections.
Zaaroura H; Geffen Y; Bergman R; Avitan-Hersh E
J Dermatol; 2018 Aug; 45(8):994-999. PubMed ID: 29897142
[TBL] [Abstract][Full Text] [Related]
39. Successful daptomycin treatment for Staphylococcus lugdunensis endocarditis.
Stair B; Vessels B; Overholser E; Zogleman B; Wall BM; Corbett C
Am J Med Sci; 2012 Jul; 344(1):64-6. PubMed ID: 22314107
[TBL] [Abstract][Full Text] [Related]
40. Staphylococcus lugdunensis: low prevalence and clinical significance in a pediatric microbiology laboratory.
German GJ; Wang B; Bernard K; Stewart N; Chan F; Pacheco AL; Wiebe D; Burdz T; Slinger R
Pediatr Infect Dis J; 2013 Jan; 32(1):87-9. PubMed ID: 23241991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
